Showing 3811-3820 of 7888 results for "".
LASIK With a Thin Flap
https://crstoday.com/crst-issues/2005-may/crst0505_rs_dougherty-html/40818/LASIK With a Thin Flap The procedure can be safely performed with minimal flap complications and good visual outcomes while minimizing ectasia risks.Global HIV/AIDS and Visual Impairment
https://crstoday.com/topics/refractive-surgery/crst1005_17-php/40696/Current worldwide trends of HIV/AIDS and the management of blinding ocular complications in the developing world.Simultaneous Bilateral Cataract Surgery
https://crstoday.com/crst-issues/2003-aug/0803_041-html/40309/There are good reasons for experienced surgeons to consider the procedure in appropriate patients.Differentiated Treatments for Dry Eye Disease (DED)
https://crstoday.com/crst-supplements/differentiated-treatments-for-dry-eye-disease-ded/differentiated-treatments-for-dry-eye-disease-ded/45419/Whether DED presents as evaporative, inflammatory, or both, physicians have a variety of tools in their treatment armamentarium.Presbyopia Perspectives: A Global Discussion
https://crstoday.com/crst-issues/2022-aug/presbyopia-perspectives-a-global-discussion/44806/A virtual roundtable showcasing surgeons’ preferred treatments and patient selection for pharmacologic agents, premium IOL technologies, and refractive procedures.AI Beyond the Clinic
https://crstoday.com/crst-issues/jan-2026/ai-beyond-the-clinic/54538/How regulation and reimbursement are accelerating AI and home monitoring.Nerve-Related Corneal Pain
https://crstoday.com/crst-issues/jan-2025/nerve-related-corneal-pain/45427/Understanding mechanisms, diagnosis, and treatment strategies.New Technologies I’m Using in 2021
https://crstoday.com/crst-issues/april-2021/new-technologies-im-using-in-2021/44434/Surgeons from around the world share their latest practice additions.Endless and Essential: the Tug-of-War Over Off-Label Use
https://crstoday.com/topics/general/endless-and-essential-the-tug-of-war-over-off-label-use/43223/Will the pendulum swing once again?Is Resistance to Gatifloxacin and Moxifloxacin Here Already?
https://crstoday.com/topics/general/crst0407_16-php/41273/New evidence suggests that the incidence of in vitro resistance to these drugs is on the rise. How do we counter this trend?